Ennov and fme Life Sciences Announce New Partnership

fme Life Sciences to offer enterprise content and data management services in support of Ennov’s Regulatory solution suite

DANBURY, CT, February 10, 2020 – Ennov and fme’s global Life Sciences Team are pleased to announce a new partnership that will provide an expanded portfolio of content and data management services to their regulatory clients.


If you would like more information about this topic, please call Nigel Whitehead at +1 475-329-2394, or email n.whitehead@fme-us.com

The Ennov Regulatory suite combines the power and fexibility of Ennov Doc, Ennov Dossier and Ennov RIM to support the entire regulatory product lifecycle from the early planning of registration targets through product retirement. The Ennov Regulatory suite is an invaluable tool for regulatory activity planning, product registration management, dossier creation, dossier management and more. Within the last twelve months, three of the top 25 pharmaceutical companies have selected Ennov as their global RIM platform to support the regulatory operations of multiple business sectors across their respective organizations.

The Life Sciences Team of fme group is a leading provider of business and technology services supporting the deployment of Content Services and ECM solutions to its clients in the Life Sciences Industry. We act as a trusted advisor and systems integration specialist across the Clinical, Regulatory and Quality and Manufacturing domains in Europe and North America.

According to Ennov CEO Olivier Pâris, “the number, size and complexity of our Regulatory projects is always increasing and we must ensure that we can scale our capabilities appropriately to ensure our clients are successful. Our partnership with fme Life Sciences provides our clients with a reliable, high quality provider of enterprise content and data management services as they prepare for their implementation of their Ennov solution.”

“Ennov continue to make a positive impact in the Life Sciences market with their Ennov Regulatory Suite and their acquisition of high profile clients has not gone unnoticed.” commented Nigel Whitehead, COO of fme US, LLC. “Our mutual clients will clearly benefit from this partnership and we’re looking forward to supporting Ennov’s growth trajectory” he added.

To learn more about Ennov and their innovative regulatory solution suite, visit www.ennov.com. To learn more about fme US’ service offerings, visit www.fme-us.com.

About fme

Digitalization enables new ways of dealing with existing businesses and creates totally new
business models. We believe in the opportunities of digital transformation and love to help our clients worldwide maintain and create competitive businesses. Our devoted consultants optimize or challenge our clients’ business models through existing and new technologies and advise them on the necessary cultural change in their company. Cloud, Business Intelligence, Social Business Collaboration and Enterprise Content Management technologies, in combination with custom software development and the ability to operate our clients’ systems 24×7, help us to add value to our clients’ transformation process.

The industry focus lies on solutions for life sciences and industrial manufacturing. We design and implement proven best practice solutions leading to improved quality and compliance, enhanced competitiveness and secured future business. To this effect, we provide vendor independent consulting services. Our teams in Germany, the United States and Romania are experienced in managing global projects and also grant access to our cost-effective near-shore resources where advisable.